The future of diabetes technology: Predictive CGM

The latest figures from the International Diabetes Federation estimate that 590 million people worldwide have diabetes, with 1 in 9 adults (aged 20 – 79 years) living with the condition. By 2050, these already stark figures are projected to rise dramatically, reaching 853 million people—a 46% increase.1 As one of the most expensive health conditions to manage, the growing rate of diabetes globally presents a pressing challenge for healthcare systems worldwide and a demand for better diabetes technology.2  

Most of the cost of diabetes care is not a result of day-to-day management, but comes from complications associated with the condition. In the United Kingdom, for example, out of the £10.7 billion spent on diabetes care, approximately 40% is spent on routine diabetes care, and the remaining 60% is spent on diabetes-related complications such as heart failure, strokes and amputations.3 Effective diabetes management, essential for avoiding complications, remains a complex task for anyone living with the disease.
Read on healthcaretransformers.com